SCHEMBL28934464

SCHEMBL28934464

COc1cc(C)ccc1-c1nnc(Cl)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.40
HPGD P15428 5/20 0.40
L3MBTL1 Q9Y468 4/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
LMNA P02545 3/20 0.40
GAA P10253 1/20 0.40
ACHE P22303 1/20 0.40
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CRHR1 P34998 3/20 0.39
KMT2A Q03164 2/20 0.37
POLB P06746 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28934436 0.90 ACHE (0.41) MAPTHPGDL3MBTL1NPC1RAB9A
SCHEMBL28934710 0.90 ACHE (0.41) MAPTHPGDL3MBTL1NPC1RAB9A
SCHEMBL28934542 0.87 MAPT (0.39) MAPTHPGDL3MBTL1NPC1RAB9A
SCHEMBL28934496 0.86 PDE5A (0.46) MAPTHPGDL3MBTL1ACHEALDH1A1
SCHEMBL30108829 0.84 THRB (0.38) MAPTHPGDNPC1RAB9AGAA
SCHEMBL28934326 0.84 ACHE (0.36) MAPTHPGDL3MBTL1RAB9ALMNA
SCHEMBL30108916 0.84 MAOA (0.37) MAPTHPGDL3MBTL1ACHEALDH1A1
SCHEMBL28934449 0.84 KDM4E (0.40) MAPTHPGDL3MBTL1NPC1RAB9A
SCHEMBL28934452 0.84 MAPT (0.39) MAPTHPGDL3MBTL1NPC1RAB9A
SCHEMBL26136379 0.84 MAOA (0.37) MAPTHPGDL3MBTL1ACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115433163-A NLRP3 inflammasome inhibitor and application thereof 药捷安康(南京)科技股份有限公司 2022-12-06 CN disclosed